Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Digestive Diseases and Sciences
|
October 1, 1986
Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals
J C Hoefs, D Aufrichtig, S Lottenberg, et al.
Alimentary Pharmacology & Therapeutics
|
December 5, 2008
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial
G T Everson, M L Shiffman, J C Hoefs, et al.
Alimentary Pharmacology & Therapeutics
|
February 13, 2008
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial
G T Everson, M L Shiffman, T R Morgan, et al.
Hepatology (Baltimore, Md.)
|
August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
K L Lindsay, C Trepo, T Heintges, et al.
The American Journal of Gastroenterology
|
December 22, 1999
Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group
D M Jensen, E L Krawitt, E B Keeffe, et al.
Hepatology (Baltimore, Md.)
|
September 26, 1997
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group
M J Tong, K R Reddy, W M Lee, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Digestive Diseases and Sciences
|
October 1, 1986
Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals
J C Hoefs, D Aufrichtig, S Lottenberg, et al.
Alimentary Pharmacology & Therapeutics
|
December 5, 2008
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial
G T Everson, M L Shiffman, J C Hoefs, et al.
Alimentary Pharmacology & Therapeutics
|
February 13, 2008
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial
G T Everson, M L Shiffman, T R Morgan, et al.
Hepatology (Baltimore, Md.)
|
August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
K L Lindsay, C Trepo, T Heintges, et al.
The American Journal of Gastroenterology
|
December 22, 1999
Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group
D M Jensen, E L Krawitt, E B Keeffe, et al.
Hepatology (Baltimore, Md.)
|
September 26, 1997
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group
M J Tong, K R Reddy, W M Lee, et al.
Page
of 5